Anti-hMAM Monoclonal Antibodies Evaluated in Breast and Non-Breast Tissues for Differential Diagnosis Implication
- 21 April 2016
- journal article
- Published by SAGE Publications in Tumori Journal
- Vol. 102 (3) , 264-269
Abstract
Purpose: Human mammaglobin (hMAM) is a breast tissue-specific marker that may have potency for the diagnosis of breast cancer. However, there is a lack of commercialization of anti-hMAM antibody made in China. Methods: Immunoreactivities of 2 self-made monoclonal anti-hMAM antibodies, MEF521 and MDA822, were evaluated by immunohistochemistry staining and compared with imported monoclonal antibody ab81611. A total of 48 cases of primary breast cancers, 36 cases of benign or normal breast tissues, 52 cases of lymph nodes or organ metastases from breast cancer, and 90 cases of non-breast primary carcinoma tissues were analyzed. Results: All 3 anti-hMAM antibodies showed high positive expression of hMAM in primary breast cancers, benign, and normal breast tissues. The positive ratio for MEF521 (33.3%) or MDA822 (44.4%) was much higher than that of ab81611 (16.7%) in lymph node metastasis from breast cancer (p = 0.038). There was no correlation between hMAM expression and clinicopathologic features of breast cancer in the 3 groups of antibodies. In 90 cases of non-breast primary carcinoma tissues, no hMAM-positive ones were observed in the MEF521 or MDA822 group, but 48 (53.3%) in the ab81611 group were positive, indicating that breast tissue specificity of the 2 self-made anti-hMAM monoclonal antibodies much higher than that of ab81611 (p<0.001). Conclusions: Our results showed that MDA822 and MEF521 are more specific to breast cancer as measured by means of immunohistochemistry. Therefore, the 2 self-made anti-hMAM antibodies may have good prospects for clinical application in the differential diagnosis of breast tumor and breast cancer metastases.Keywords
This publication has 18 references indexed in Scilit:
- Peripheral blood mammaglobin gene expression for diagnosis and prediction of metastasis in breast cancer patientsAsia-Pacific Journal of Clinical Oncology, 2012
- Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell depositsBMC Cell Biology, 2010
- Diagnosis and Origin Determination of Malignant Pleural Effusions Through the Use of the Breast Cancer Marker Human MammaglobinDiagnostic Molecular Pathology, 2010
- Detection of Cytokeratin 19, Human Mammaglobin, and Carcinoembryonic Antigen-Positive Circulating Tumor Cells by Three-Marker Reverse Transcription-Pcr Assay and Its Relation to Clinical Outcome in Early Breast CancerThe International Journal of Biological Markers, 2010
- Mammaglobin as a potential molecular target for breast cancer drug deliveryCancer Cell International, 2009
- Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignanciesBMC Cancer, 2006
- Mammaglobin-A is a tumor-associated antigen in human breast carcinomaSurgery, 2003
- Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodesInternational Journal of Cancer, 2001
- Detection of mammaglobin expressing cells in blood of breast cancer patientsCancer Letters, 2000
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975